Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com FDA COMPLETES REVIEW OF THIRD PMA MODULE Key Highlights • Module 3 is the largest PMA module and covers non-clinical bench testing...
FDA Completes Review of Third PMA Module
Filed with ASX · · 2 pages · English
Release
Imricor Medical Systems, Inc. on 6ix
Earlier from Imricor Medical Systems
- Cleansing Notice
- Application for quotation of securities - IMR
- S&P DJI Announces September 2026 Quarterly Rebalance
- FDA Accepts Imricor PMA Manufacturing Module
- Release from Voluntary Escrow
Later from Imricor Medical Systems
- Notification regarding unquoted securities - IMR
- Notification of cessation of securities - IMR
- Q3 FY26 Results Webinar Notification
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems